Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function

ACS Chem Neurosci. 2019 May 15;10(5):2229-2236. doi: 10.1021/acschemneuro.8b00733. Epub 2019 Mar 20.

Abstract

Altered intestinal permeability has been correlated with Parkinson's pathophysiology in the enteric nervous system, before manifestations in the central nervous system (CNS). The inflammatory endotoxin or lipopolysaccharide (LPS) released by gut bacteria is known to modulate α-synuclein amyloidogenesis through the formation of intermediate nucleating species. Here, biophysical techniques in conjunction with microscopic images revealed the molecular interaction between lipopolysaccharide and α-synuclein that induce rapid nucleation events. This heteromolecular interaction stabilizes the α-helical intermediates in the α-synuclein aggregation pathway. Multitude NMR studies probed the residues involved in the LPS-binding structural motif that modulates the nucleating forms, affecting the cellular internalization and associated cytotoxicity. Collectively, our data characterizes this heteromolecular interaction associated with an alternative pathway in Parkinson's disease progression.

Keywords: DEST; Lipopolysaccharide; STD; fluorescence; α-synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Enteric Nervous System / metabolism
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Lipopolysaccharides / pharmacology*
  • Neurons / drug effects
  • Neurons / metabolism
  • Permeability
  • Protein Aggregates / drug effects*
  • alpha-Synuclein / metabolism*

Substances

  • Lipopolysaccharides
  • Protein Aggregates
  • alpha-Synuclein